Mana.bio

mana.bio

Mana.bio is an AI-based drug delivery startup that focuses on gene therapy, including DNA and RNA-based therapeutics and vaccines. The company leverages machine learning and nanotechnology to create novel lipid nanoparticle (LNP) drug delivery systems aimed at targeted extrahepatic delivery of nucleic acid therapeutics. Founded by a team of experienced entrepreneurs and experts in drug delivery and software development, Mana.bio aims to disrupt the drug delivery space and has been recognized as one of Israel's top 20 promising startups. The company is in the seed stage and has recently partnered with notable organizations to advance its innovative solutions in RNA delivery.

Is this your company?